Stem cells: New frontiers of ethics, law, and policy

Neurosurgical Focus

Volumn 24, Issue 3-4, 2008, Pages

  Scott, Christopher Thomas ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Embryo research; Embryonic stem cell; Ethics; Law; Policy; Stem cell

Indexed keywords

EMBRYO RESEARCH; ETHICS; GOVERNMENT REGULATION; HUMAN; LEGAL ASPECT; MANAGEMENT; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

EMBRYO RESEARCH; GOVERNMENT REGULATION; HUMANS; POLICY MAKING; RESEARCH EMBRYO CREATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 42149083502     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/FOC/2008/24/3-4/E22     Document Type: Article

References (28)

1. Associated Press: Biotech firms read coolly to new stem cell findings. November 21, 2007. (http://www.komotv.com/news/tech/11697266.html) [Accessed 21 January, 2008]
2. Capowski EE, Schneider BL, Ebert AD, Seehus CR, Szulc J, Zufferey R, et al: Lentiviral vector-mediated modification of human neural progenitor cells for ex vivo gene therapy. J Neurosci Methods 163:338-349, 2007
3. Cummings, BJ, Uchida, N, Tamaki, SJ, Anderson AJ: Human neural stem cell differentiation: association with recovery of locomotor function. Neur Res 28:474-481, 2006
4. Dawson L, Bateman-House AS, Mueller Agnew D, Bok H, Brock DW, Chakravarti A, et al: Safety issues in cell-based intervention trials. Fertil Steril 80:1077-1085, 2003
5. Dihné M, Bernreuther C, Haget C, Wesche KO, Schachner M: Embryonic stem cell-derived neuronally committed precursor cells with reduced teratoma formation after transplantation into the lesioned adult mouse brain. Stem Cells 24:1458-1466, 2006
6. Drukker M, Katchman H, Katz G, Even-Tov Fiedman S, Shezen E, Hornstein E, et al: Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24:221-229 2006
7. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, et al: Treatment of sickle cell anemia mouse model with iPS cells generated from autologous akin. Science 318:1920-1923, 2007
8. Hanna K: Ball of confusion: how stem cells have stymied review boards. Research Practitioner 8:128-136, 2007
9. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, et al: Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25:4694-4705, 2005
10. Lindvall O, Kokaia Z: Stem cells for the treatment of neurological disorders. Nature 441:1094-1096, 2006
11. Lo B, Zettler P, Cedars MI, Gates E, Kriegstei AR, Oberman M, et al: A new era in the ethics of human embryonic stem cell research. Stem Cells 23:1454-1459, 2005
12. Lomax GP, Hall ZW, Lo B: Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards. PLoS Med 4: e114, 2007
13. Lombardo A, Genovese P, Beausejour CM, Colleoni S, Lee YL, Kim KA, et al: Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25:1298-1306, 2007
14. Magnus D, Cho M: Ethics. Issues in oocyte donation for stem cell research. Science 308:1747-1748, 2006
15. Nakagawa M, Koyanagi M, Tanabe K, Takahashi & Ichisaka T, Aoi T, et al: Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101-106, 2008
16. Okamura RM, Lebkowski J, Au M, Priest CA, Denham J, Majumdar AS: Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells. J Neuroimmunol 192:134-144, 2007
17. Owens-Smith J, McCormick J: An innovation gap in ES cell research. Nat Biotechnol 24:391-392, 2006
18. Plomer A, Taymor KT, Scott CT: Challenges to embryonic stem cell patents. Cell Stem Cell 2:13-17, 2008
19. Revazova ES, Turovets NA, Kochetkova OD, Agapova LS, Sebastian JL, Pryzhkova MV, et al: HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells [epub ahead of print], 2007
20. Shibata H, Ageyama N, Tanaka Y, Kishi Y, Sasaki E, Nakamura S, et al: Improved safety of hematopoietic transplantation with monkey embryonic stem cells in the allogeneic setting. Stem Cells 24:1450-1457, 2006
21. Silani V, Cova L, Corbo M, Ciammola A, Polli E: Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 364:200-202, 2004
22. Starck C: Embryonic stem cell research according to German and European law. German Law J 7:625-656, 2006
23. Stayn S: A guide to state laws on hESC research: a call for interstate dialogue. BNA Med Law Pol Rep 5:718-725, 2006
24. Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, Ditunno JF, et al: Guidelines for the conduct of clinical trials for spinal cord injury (SCI, as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 45:206-221, 2007
25. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872, 2007
26. Ubel P, Loewenstein G, Jepson C: Whose quality of life? A commentary exploring discrepancies between health state evaluations and the general public. Quality Life Res 12:599-607, 2003
27. Weissman I: Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287:1442-1446, 2000
28. Zettler P, Wolf LE, Lo B: Establishing procedures for institutional oversight of stem cell research. Acad Med 82:6-10, 2007